Cantillon Capital Management LLC Sells 369,809 Shares of Agilent Technologies, Inc. $A

Cantillon Capital Management LLC lowered its position in Agilent Technologies, Inc. (NYSE:A) by 11.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,745,829 shares of the medical research company’s stock after selling 369,809 shares during the quarter. Agilent Technologies makes up approximately 2.1% of Cantillon Capital Management LLC’s portfolio, making the stock its 22nd biggest position. Cantillon Capital Management LLC owned about 0.97% of Agilent Technologies worth $312,970,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of A. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after acquiring an additional 24,687 shares during the last quarter. Massachusetts Financial Services Co. MA grew its position in Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after acquiring an additional 1,713,216 shares during the last quarter. CCLA Investment Management grew its position in Agilent Technologies by 1.9% during the 4th quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock worth $142,542,000 after acquiring an additional 19,518 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in Agilent Technologies by 20.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock worth $7,269,000 after purchasing an additional 9,236 shares during the period. Finally, Oak Thistle LLC purchased a new position in Agilent Technologies in the 4th quarter worth approximately $3,457,000.

Agilent Technologies Trading Down 0.1%

Shares of A opened at $131.34 on Monday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The firm’s 50-day moving average price is $127.49 and its 200-day moving average price is $125.54. The firm has a market capitalization of $37.09 billion, a price-to-earnings ratio of 26.37, a PEG ratio of 2.34 and a beta of 1.25.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts anticipate that Agilent Technologies, Inc. will post 6 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies’s payout ratio is currently 20.48%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on A. Bank of America raised Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price objective for the company from $150.00 to $145.00 in a research note on Thursday, May 28th. Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price on the stock. Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Robert W. Baird raised their price target on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Finally, Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $159.35.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.